Cargando…
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
Danshen (salvia miltiorrhiza Bunge) is widely used in traditional Chinese medicine. However, it is definite clinical effort and mechanism on breast cancer is unclear. In our study, we used the real-world database to investigate in vivo protective effort of danshen in the breast cancer patients throu...
Autores principales: | Lin, Yu-Shih, Shen, Yi-Chia, Wu, Ching-Yuan, Tsai, Ying-Ying, Yang, Yao-Hsu, Lin, Yin-Yin, Kuan, Feng-Che, Lu, Cheng-Nan, Chang, Geng-He, Tsai, Ming-Shao, Hsu, Cheng-Ming, Yeh, Reming-Albert, Yang, Pei-Rung, Lee, I-Yun, Shu, Li-Hsin, Cheng, Yu-Ching, Liu, Hung-Te, Wu, Yu-Huei, Wu, Yu-Heng, Chang, De-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836808/ https://www.ncbi.nlm.nih.gov/pubmed/31736748 http://dx.doi.org/10.3389/fphar.2019.01226 |
Ejemplares similares
-
Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I
por: Wu, Ching-Yuan, et al.
Publicado: (2023) -
Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021) -
Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway
por: Wu, Ching-Yuan, et al.
Publicado: (2017) -
Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway
por: Lee, I-Yun, et al.
Publicado: (2018) -
Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
por: Su, Hui-Chen, et al.
Publicado: (2023)